Zirtek

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zirtek

Property Description
Active ingredient Cetirizine Hydrochloride
Form Tablet and Oral solution
Pharmacological class Second-generation H₁-receptor antagonist
Common purpose Relief from symptoms of allergic conditions
Origin Synthetic (derived from Hydroxyzine)

What is Zirtek and What Type of Drug is it?

Zirtek is a medicinal product whose active ingredient is Cetirizine Hydrochloride, which is classified pharmacologically as a synthetic second-generation antihistamine. Its primary function involves acting as a highly selective peripheral H1-receptor antagonist, blocking the actions of the chemical messenger histamine, which the body releases during an allergic response. The drug’s non-sedating profile has been broadly recognized in pharmacological studies, offering a safety advantage over older classes. Cetirizine is a non-sedating H1-antagonist used for various allergic conditions.

Chemically, Cetirizine is a piperazine derivative whose structure limits its ability to cross the blood-brain barrier. This structural characteristic ensures that the drug delivers its targeted anti-allergic effect predominantly in the periphery, which minimizes the potential for generalized sedation. The drug is characterized by its H1-receptor antagonism and its specific mode of interaction with histamine.

Cetirizine Hydrochloride: Composition, Forms, and General Purpose

The product is a single-component product (monotherapy), containing only Cetirizine Hydrochloride as its active constituent, prepared for oral administration. The drug is readily available in two primary dosage forms: the solid tablet (often film-coated) and an oral solution (liquid). This dual format is key to the product's positioning, facilitating administration for both adults and children.

The general therapeutic purpose of Zirtek is to provide sustained relief from the discomfort and visible signs of allergic conditions, such as persistent itching or a runny nose. The medicine’s reputation for providing consistent relief is well-established, offering a reliable option for the effective control of allergic symptoms.

What side effects are possible with Zirtek?

Possible Side Effects and Safety Information

The safety profile of Zirtek (Cetirizine Hydrochloride) is officially documented by government regulatory agencies using frequency classifications based on System-Organ Class (SOC) categories. These classifications indicate how often adverse reactions have been observed in clinical trials and post-marketing surveillance.


Frequency-Classified Adverse Reactions

Common reactions (affecting 1 in 10 to 1 in 100 patients) often include somnolence (sleepiness), headache, fatigue, and dry mouth. Uncommon reactions (1 in 100 to 1 in 1,000) may involve pruritus (itching), rash, or abdominal pain.

Rare reactions (1 in 1,000 to 1 in 10,000) include hypersensitivity reactions, convulsions, tachycardia (increased heart rate), and abnormal liver function tests. Very Rare reactions (less than 1 in 10,000) include severe events such as anaphylactic shock and angioedema (serious swelling).


Safety Considerations and Restrictions

Certain reactions, such as somnolence and fatigue, are more frequently observed at the start of treatment as stated in regulatory labeling. Furthermore, the recurrence or appearance of intense pruritus and/or urticaria upon discontinuation has been noted, particularly following long-term use.

Safety constraints require caution for specific populations. For patients with renal impairment, dose adjustment is specified, and the medication is contraindicated in individuals with end-stage renal disease. Caution is also advised in patients with predisposing factors for urinary retention or a history of convulsions.

Overdose and Emergency Response

Overdose and when to seek help

Overdose scope

Feature Official Regulatory Finding
Documented overdose presentations Overdose manifestations primarily involve Central Nervous System (CNS) effects such as somnolence, confusion, sedation, dizziness, and stupor. Other presentations include tachycardia (rapid heart rate), urinary retention, and mydriasis (pupil dilation).
Dose-related or exposure-related factors Manifestations have been reported following ingestion of at least five times the recommended daily dose.
Population-specific overdose notes In children, documented effects include episodes of extreme activity or agitation followed by profound lethargy.
Emergency-response statements Get medical help or contact a Poison Control Center right away for any suspected overdose.
When immediate medical help is required (label-derived phrasing only) Urgent help is required if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened (unconsciousness).

Overdose classifications (high-level)

Feature Official Regulatory Finding
Severity classification Overdose may lead to severe manifestations requiring urgent medical assistance.
Overdose-context constraints No known specific antidote is available for Cetirizine.

Resulting overdose structure

  • Documented signs of overdose, such as stupor or tachycardia, signal the need for immediate medical evaluation.
  • The mandated action is to seek assistance from emergency services immediately if the affected person exhibits severe outcomes like collapse or a seizure.
  • No known specific antidote is available for Cetirizine, and management is therefore restricted to providing symptomatic or supportive treatment.

Connection to the overall overdose profile

Regulatory documents define the overdose profile by listing specific systemic manifestations, emphasizing that certain severe outcomes such as seizure or inability to be awakened constitute mandatory emergency triggers for seeking immediate medical assistance. The management approach is constrained by the official statement that no specific antidote exists, focusing treatment entirely on supportive care.

Therapeutic Uses of Zirtek

Main Uses and Benefits of Zirtek

Zirtek is a second-generation antihistamine used to manage symptoms associated with allergic reactions. Its primary function is to block the effects of histamine, a natural substance in the body that triggers allergic symptoms when the immune system reacts to an external allergen.

Allergic Rhinitis

Zirtek is used to treat both seasonal and perennial allergic rhinitis. Seasonal allergic rhinitis, often referred to as hay fever, occurs at specific times of the year in response to outdoor allergens such as pollen from trees, grasses, and weeds. Perennial allergic rhinitis occurs year-round and is typically caused by indoor allergens, including dust mites, pet dander, and mold.

By managing these conditions, the medication helps alleviate common respiratory symptoms, such as:

  • Sneezing: Reducing the frequency and intensity of sneezing fits.
  • Rhinorrhea: Decreasing the production of excess mucus (runny nose).
  • Nasal Pruritus: Relieving itching sensations within the nose.
  • Ocular Symptoms: Addressing redness, itching, and watery eyes associated with allergic conjunctivitis.

Chronic Urticaria

Beyond respiratory allergies, Zirtek is indicated for the treatment of chronic idiopathic urticaria, also known as hives. This condition is characterized by the sudden appearance of itchy, raised red bumps or wheals on the skin that persist for six weeks or longer without a clear external cause.

The benefits for skin-related allergic reactions include:

  • Reduction of Wheals: Decreasing the number and size of hives.
  • Itch Relief: Mitigating the persistent pruritus (itching) that often accompanies hives.
  • Improved Comfort: Reducing the overall skin irritation and discomfort associated with chronic skin reactions.

Mechanism and Efficacy

As a non-sedating or minimally sedating antihistamine, Zirtek is designed to provide relief from symptoms without the significant drowsiness often associated with first-generation antihistamines. Its long-acting formulation typically allows for symptom management over a 24-hour period, providing sustained relief from the discomfort of daily allergy triggers.

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Zirtek — Official Regulatory Information


Eligibility Scope

  • Populations for whom use is allowed (as stated in label): Adults, adolescents (over 12 years), and children (over 6 years for tablets; over 2 years for most oral solutions).
  • Populations for whom use is not recommended (if applicable): Children less than 6 years of age for the film-coated tablet formulation.
  • Populations for whom use is contraindicated: Patients with severe renal impairment (End-Stage Renal Disease or CLcr below 10 or 15 mL/min) and individuals with known hypersensitivity to the active substance, hydroxyzine, or piperazine derivatives.
  • Age-related eligibility rules: The tablet formulation is not recommended for children under 6 years as it does not allow for appropriate dose adaptation. Older adults require no dose reduction if their renal function is normal.
  • Condition-specific eligibility rules: Patients with moderate renal impairment ( CrCL < 50 mL/min) are eligible only when an adjusted dose is administered. No dose adjustment is needed for solely hepatic impairment.
  • Pregnancy and lactation eligibility status (if explicitly documented): Use requires caution. Cetirizine passes into breast milk, meaning a risk of infant side effects cannot be excluded.
  • Eligibility-related restrictions: Caution is mandated for patients with a predisposition to urinary retention (e.g., prostatic hyperplasia) or those who are epileptic or at risk of convulsions.

Resulting Eligibility Structure

The official regulatory documents strictly define eligibility by establishing absolute contraindications based on allergy history and severe kidney disease. For all other populations, eligibility is defined by a set of conditional restrictions related to minimum age, the need for dose adjustment based on renal function, and specific comorbidities that require documented caution. These classifications serve as the final determinants of population eligibility.

What should I know about interactions with other medicines?

The official regulatory profile for Zirtek (Cetirizine Hydrochloride) documents specific interaction patterns with other substances.

A pharmacodynamic interaction is the risk of additive impairment of mental alertness and performance when co-administered with alcohol or other Central Nervous System (CNS) depressants, such as sedatives and tranquilizers. This combination is officially noted to cause additional reductions in CNS function.

Regarding pharmacokinetic interactions, co-administration with a daily dose of Theophylline (400 mg) causes a documented 16% decrease in the clearance of cetirizine. Conversely, clinical studies found no clinically significant interaction when cetirizine was co-administered with agents like Ketoconazole, Erythromycin, Azithromycin, or Pseudoephedrine.

The interaction with food is formally documented as affecting the rate of absorption: while the total extent of absorption (AUC) is unchanged, food measurably reduces the peak plasma concentration (Cmax) and delays the time to peak concentration (Tmax).

Population-specific pharmacokinetic notes indicate that individuals with Hepatic or Renal Impairment and Geriatric Patients may experience decreased clearance, which leads to a greater systemic exposure. The medicine is contraindicated for use in patients with end-stage renal disease and known hypersensitivity to Cetirizine or Hydroxyzine.

Mechanism of Action

Zirtek, which contains the active ingredient cetirizine, functions as a highly selective inverse agonist of the histamine H1 receptor (H1). The drug targets and competitively binds to the H1 receptor, primarily in peripheral tissues. Its molecular mechanism involves stabilizing the receptor in an inactive conformation. This interaction type effectively prevents the endogenous ligand, histamine (released by mast cells and basophils), from binding to and activating the H1 receptor site.

This molecular interaction modulates the downstream signaling pathway. Normal histamine-mediated H1 receptor activation triggers a Gq protein signaling cascade that ultimately results in the release of intracellular calcium. By stabilizing the inactive receptor, cetirizine blocks this G-protein signaling cascade. The suppression of this intracellular process prevents the physiological consequences of histamine release, specifically the localized increase in vascular permeability, smooth muscle contraction, and stimulation of sensory nerve fibers.

Dosage and Administration Information

Instruction Map: How to use Zirtek — Official Administration Guidelines


The administration protocol for the active ingredient, Cetirizine Hydrochloride, is standardized across its approved formats. The primary routes of administration include oral (tablet and solution) and intravenous (IV) injection for use in specific acute clinical settings. For most users, the dosage schedule for Zirtek is defined as 10 mg taken once daily, which constitutes the maximum recommended daily dose.

Administration Scope

Feature Official Instruction
Route of administration: Primarily Oral (tablet, oral solution). Intravenous route is approved for acute, supervised use.
Dosing schedule: Adults/Adolescents (ge 12 years): Standard dose is 10 mg once daily. Children (6 to 12 years): The dose is 5 mg twice daily in some regions.
Timing in relation to meals (if applicable): The oral formulation can be taken without regard to food consumption.
Preparation requirements (if applicable): Tablets should be swallowed with a glass of liquid. Oral solution must be measured using a calibrated dosing cup.
Age-group administration rules: The tablet formulation is not suitable for children under 6 years as it prevents necessary small dose adjustments.
Missed-dose rules: Take the missed dose as soon as remembered; if nearly time for the next dose, skip the missed dose and do not take a double dose.
Special procedural conditions: Renal Impairment: Dose adjustment is mandatory, often to 5 mg once daily or less frequently.

Instruction Classifications (High-Level)

Classification Pattern
Administration method type: Oral and Intravenous
Frequency pattern: Once daily (q.d.) for adults/adolescents, or a divided twice daily (b.i.d.) regimen for specific pediatric use.

Resulting Procedural Structure

Connection to the overall use protocol (2–4 sentences):

This standardized protocol establishes a clear, once-daily oral regimen as the default use for Zirtek, emphasizing consistency and simplicity for most users. The protocol is structurally modified only to accommodate specific factors such as age and mandatory reduction for impaired renal clearance. These rules strictly define the approved routes and official dosing amounts to ensure standardized administration.

Recent Clinical Evidence

Research evidence / Overview of Studies for Zirtek

The research for Zirtek (Cetirizine Hydrochloride) is primarily structured around studies exploring the product in conditions characterized by fluctuating or episodic manifestations, such as various types of allergic rhinitis and chronic hives. Clinical evaluation is largely based on short-term, randomized controlled trials (RCTs).


Evidence Base for Seasonal Allergic Rhinitis (SAR)

Research was conducted using short-term, randomized controlled trials where the product was evaluated against a placebo or an active comparator. These studies monitored outcomes related to specific nasal and eye symptoms, and patient-reported outcomes describing perceived discomfort. The trials reported measurements of symptom score changes and described patterns observed in the studies regarding the evolution of physical discomfort. Systematic reviews have been used to contextualize data showing how patients reported their experience when the product was evaluated during periods of heightened symptom activity. There is limited information for long-term outcomes regarding the sustained control or durability of effects after the standard few weeks of study.


Evidence Base for Perennial Allergic Rhinitis (PAR)

For year-round allergies, intermediate-term randomized controlled trials research examined changes in overall symptom scores over several weeks to a few months. Study populations included adults and children. The findings describe patterns observed in the studies regarding changes measured during the study period for outcomes linked to inflammatory or irritative states. Studies report that patterns related to specific outcomes may vary. Comparative evidence remains limited regarding outcomes from high-dose strategies.


Evidence in Specific Patient Populations (Children and Older Adults)

Research has been conducted in specific patient groups beyond the general adult population, including children (aged geq 6 months or geq 2 years, depending on the indication). The dosing for liquid forms in younger patients was observed in studies examining outcomes related to systemic or functional imbalance. Research provides context but not individual predictions, and the findings describe group patterns applicable to the populations studied.


Research Gaps and Areas of Uncertainty

The research highlights areas where further study is needed. The certainty remains low regarding sustained, long-term outcomes—that is, the ability to maintain symptom patterns over many months—because follow-up durations were limited in many primary efficacy trials. Data for certain groups remain insufficient, particularly concerning individuals who experience persistent or unresponsive symptoms and where high-dose strategies have been evaluated in research.

Frequently Asked Questions (FAQ)

Common questions about Zirtek (FAQ)

Q: How quickly does Zirtek start to work?

According to the official product information, the activity of the standard dose begins relatively quickly. Studies indicate that antihistaminic activity started within 20 minutes in many subjects, and in the majority of subjects studied, it began within one hour after taking the medicine.

Q: How long does the effect of Zirtek last?

Regulatory documents describe the duration of activity based on clinical observations. Studies have shown that the antihistaminic effect from the standard dose persists for at least 24 hours. This sustained action is consistent with a once-daily regimen.

Q: Can Zirtek be used to treat hives (urticaria)?

Yes, official labeling includes the treatment of hives. Zirtek is indicated for the relief of symptoms associated with various types of urticaria, which is a condition involving the swelling, redness, and itchiness of the skin.

Q: What makes Zirtek different from a decongestant?

Zirtek's active ingredient, cetirizine, is a second-generation antihistamine that primarily works to block the effects of histamine during an allergic reaction. A decongestant is a separate class of medicine that focuses on relieving nasal stuffiness. For this reason, Zirtek is sometimes combined with a decongestant in a single product, demonstrating that they are distinct types of medicine.

Q: Is it safe to drive after taking Zirtek?

Official warnings advise individuals to be careful when performing tasks that require mental alertness. Because drowsiness or sleepiness (somnolence) may occur, official warnings advise individuals to be careful when driving a motor vehicle or operating machinery until they know how the product affects them.

Q: Can Zirtek be taken while pregnant or breastfeeding?

If you are pregnant, the regulatory guidance is to consult a health professional before using Zirtek. During breastfeeding, official information advises against use or mandates caution because cetirizine is known to pass into breast milk.

Q: Are there any long-term side effects associated with Zirtek use?

Safety updates have been required by health authorities regarding the discontinuation of long-term use. In rare instances, patients who stop taking the medicine after a prolonged period may experience severe itching (pruritus). This discomfort can sometimes be managed by restarting or tapering the dose.

Q: Why do some people take Zirtek at night?

This usage pattern is often related to the product’s official safety profile. Somnolence (sleepiness) and fatigue are noted as common side effects. Taking the dose in the evening may be a way to help reduce any potential impact of drowsiness during the day.

Q: Is Zirtek a steroid?

No. Official documents classify the active ingredient, cetirizine, as a second-generation H1-receptor antagonist, which is the medical term for a type of antihistamine. It is chemically and functionally distinct from steroid medications.

Q: Can Zirtek cause stomach upset?

Yes, gastrointestinal symptoms have been reported in official adverse reaction data. Less common reactions (uncommon, affecting 1 in 100 to 1 in 1,000 users) may include reports of abdominal pain and nausea.

Q: Can Zirtek be taken every day for long periods?

Zirtek is approved for use in conditions that may require continuous daily administration, such as perennial allergic rhinitis. However, regulatory information generally suggests medicines be used for the duration necessary to control symptoms.

Q: What happens if I stop taking Zirtek suddenly?

After stopping the medication, especially following long-term use, there have been rare reports of patients experiencing the sudden recurrence of severe itching (pruritus). This is a documented discontinuation effect, although its resolution timeline is individual.

Q: Can I take Zirtek if I have high blood pressure?

Regulatory documents for Zirtek (cetirizine only) do not generally list high blood pressure as a caution. However, certain combination products that contain cetirizine along with a decongestant often include warnings related to high blood pressure.

Q: Are there any specific foods I should avoid while using Zirtek?

Official instructions state that no specific foods need to be avoided while taking the product. While food consumption may slightly slow down the rate at which the medicine is absorbed, it does not change the total amount of medicine that enters the systemic circulation.

Q: Does Zirtek affect birth control pills?

Regulatory-level studies used to determine drug interactions generally indicate no known interaction between cetirizine and hormonal birth control pills. However, if there are specific concerns, official documents advise caution with all co-administered substances.

Q: Can Zirtek cause anxiety or restlessness?

While Zirtek is generally known for its sedating effects, regulatory surveillance data has noted that some patients may experience rare paradoxical effects, including feelings of restlessness or anxiety. These reports come from the post-marketing phase of monitoring.

Q: Is there a generic version of Zirtek available?

Yes. The active ingredient in Zirtek, cetirizine hydrochloride, is widely available as a generic product. Regulatory agencies have determined that these generic products are therapeutically equivalent to the branded product.

Q: Does Zirtek have a different name in other countries?

Yes, official regulatory reviews across different regions have noted the existence of various associated brand names for products containing cetirizine. This is a common practice for medicines sold internationally.

Q: Does Zirtek help with pet allergies?

Zirtek is indicated for symptoms of perennial allergic rhinitis, which refers to year-round allergies. This category commonly includes sources like house dust mites and pet dander (from dogs or cats).

Q: What are the known interactions between Zirtek and herbal supplements?

There is limited official data definitively confirming the safety of all combinations with herbal remedies. Caution is advised when considering supplements that are known to cause effects like drowsiness, dry mouth, or difficulty with urination.

Q: Is Zirtek addictive?

No. Regulatory agencies have not classified Zirtek as a controlled substance, and the official labeling contains no warnings or information regarding potential for dependence or addiction.

Q: Can Zirtek be taken for non-allergy related itchiness?

Official indications confirm Zirtek is used for the treatment of chronic idiopathic urticaria and some forms of pruritus (itching) that are linked to allergic origins. However, its approved use focuses primarily on relieving symptoms of allergic conditions.

Q: How is the safety of Zirtek monitored by health authorities?

Health authorities monitor the product's safety by continuously reviewing Adverse Reaction reports collected from both clinical trials and post-marketing surveillance. This process is what leads to the official frequency classifications of side effects (e.g., Common or Rare).

Q: Does Zirtek work for all types of allergic reactions?

Zirtek is officially indicated for treating symptoms associated with certain conditions, specifically seasonal and perennial allergic rhinitis (e.g., hay fever) and urticaria (hives). Its use is not claimed or approved to treat all possible types of severe allergic reactions, such as anaphylaxis.

Q: What is the legal status of Zirtek in terms of over-the-counter availability?

In many regions, including the United States, Zirtek (cetirizine HCl) is designated as an Over-The-Counter (OTC) medicine. This means it can be purchased without a prescription.

Q: Is Zirtek gluten-free?

Official labeling typically focuses on the active ingredient and core excipients, and may not contain a direct 'gluten-free' certification. For individuals with celiac disease or severe gluten intolerance, reviewing the full excipient list or consulting a health professional is generally suggested.

Q: Does Zirtek contain any dyes or common allergens?

The official excipients list for the tablets confirms the presence of standard inactive ingredients, such as Lactose Monohydrate and Titanium Dioxide (E 171). For any specific allergen concerns, the full inactive ingredients list on the regulatory label should be reviewed.

Q: Is Zirtek suitable for children of all ages?

No. The eligibility and required dosage form are age-dependent according to official guidelines. For instance, the film-coated tablets are typically only recommended for children aged 6 years and above, with different guidelines for younger children.

Q: How often can I take Zirtek in a week?

The recommended maximum dosing frequency for the majority of eligible individuals (adults and children over 6 years) is once daily. This consistent, daily regimen is the basis of its approved use.

How should Zirtek be stored and disposed of?

How to Store and Dispose of Zirtek

Official regulatory labeling dictates specific conditions for storing and discarding Zirtek (cetirizine hydrochloride) to maintain product stability and ensure public safety.


Storage Requirements

Zirtek film-coated tablets do not require any special storage temperature conditions, while the Oral Solution must be stored at controlled room temperature (e.g., 68 F to 77 F). The medicine must be kept in its original package to protect it from light and moisture, and it must not be frozen. All forms of Zirtek must be kept out of the sight and reach of children and should not be used past the printed expiry date.


Disposal Instructions

Dispose of any unused or expired Zirtek according to local requirements. Do not dispose of the medicine via wastewater (e.g., flushing down the toilet). The preferred method for disposal is often a drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zirtek found in:

A-Z Index: